- Home
- CLLS vs PEBK Comparison
CLLS vs PEBK Comparison
Compare CLLS & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- PEBK
- Stock Information
- Founded
- CLLS 1999
- PEBK 1912
- Country
- CLLS France
- PEBK United States
- Employees
- CLLS N/A
- PEBK N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- PEBK Major Banks
- Sector
- CLLS Health Care
- PEBK Finance
- Exchange
- CLLS Nasdaq
- PEBK Nasdaq
- Market Cap
- CLLS 148.1M
- PEBK 169.6M
- IPO Year
- CLLS 2007
- PEBK N/A
- Fundamental
- Price
- CLLS $1.45
- PEBK $25.72
- Analyst Decision
- CLLS Buy
- PEBK
- Analyst Count
- CLLS 3
- PEBK 0
- Target Price
- CLLS $7.00
- PEBK N/A
- AVG Volume (30 Days)
- CLLS 120.5K
- PEBK 8.9K
- Earning Date
- CLLS 05-27-2025
- PEBK 04-29-2025
- Dividend Yield
- CLLS N/A
- PEBK 3.53%
- EPS Growth
- CLLS N/A
- PEBK 7.58
- EPS
- CLLS N/A
- PEBK 2.98
- Revenue
- CLLS $49,217,000.00
- PEBK $82,079,000.00
- Revenue This Year
- CLLS $1.26
- PEBK N/A
- Revenue Next Year
- CLLS N/A
- PEBK N/A
- P/E Ratio
- CLLS N/A
- PEBK $8.63
- Revenue Growth
- CLLS 435.38
- PEBK 7.90
- 52 Week Low
- CLLS $1.10
- PEBK $23.74
- 52 Week High
- CLLS $3.38
- PEBK $33.31
- Technical
- Relative Strength Index (RSI)
- CLLS 60.38
- PEBK 44.11
- Support Level
- CLLS $1.40
- PEBK $25.10
- Resistance Level
- CLLS $1.56
- PEBK $27.10
- Average True Range (ATR)
- CLLS 0.09
- PEBK 1.41
- MACD
- CLLS 0.03
- PEBK -0.03
- Stochastic Oscillator
- CLLS 76.09
- PEBK 41.95
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh, and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.